Mary Quirk

615 total citations
34 papers, 500 citations indexed

About

Mary Quirk is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Mary Quirk has authored 34 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 7 papers in Immunology and 6 papers in Virology. Recurrent topics in Mary Quirk's work include Cytomegalovirus and herpesvirus research (11 papers), HIV Research and Treatment (6 papers) and Herpesvirus Infections and Treatments (6 papers). Mary Quirk is often cited by papers focused on Cytomegalovirus and herpesvirus research (11 papers), HIV Research and Treatment (6 papers) and Herpesvirus Infections and Treatments (6 papers). Mary Quirk collaborates with scholars based in United States, Canada and United Kingdom. Mary Quirk's co-authors include M C Jordan, Robin Saltzman, Guy Boivin, Timothy M. Collins, M. Colin Jordan, Alejo Erice, Szu‐Yi Chou, Carol A. Olson, Marshall I. Hertz and C A Olson and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Mary Quirk

33 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Quirk United States 10 442 106 96 81 63 34 500
A Arvin United States 12 471 1.1× 96 0.9× 125 1.3× 60 0.7× 58 0.9× 34 545
Veronica Sullivan United States 7 551 1.2× 66 0.6× 68 0.7× 70 0.9× 145 2.3× 11 612
Charlene K. Edelman United States 12 299 0.7× 66 0.6× 100 1.0× 134 1.7× 50 0.8× 16 476
D. Gor United Kingdom 7 792 1.8× 79 0.7× 125 1.3× 210 2.6× 191 3.0× 12 855
H. I. J. Thomas United Kingdom 13 337 0.8× 89 0.8× 76 0.8× 208 2.6× 18 0.3× 23 518
María Ángeles Clari Spain 16 621 1.4× 173 1.6× 28 0.3× 151 1.9× 116 1.8× 32 685
P Wertheim Netherlands 10 231 0.5× 76 0.7× 31 0.3× 45 0.6× 49 0.8× 14 430
Pamela Stepick‐Biek United States 8 314 0.7× 238 2.2× 82 0.9× 59 0.7× 45 0.7× 8 598
Beatriz Muñoz‐Cobo Spain 13 389 0.9× 105 1.0× 19 0.2× 96 1.2× 67 1.1× 19 437
P Lanzarini Italy 10 199 0.5× 60 0.6× 26 0.3× 106 1.3× 20 0.3× 24 342

Countries citing papers authored by Mary Quirk

Since Specialization
Citations

This map shows the geographic impact of Mary Quirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Quirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Quirk more than expected).

Fields of papers citing papers by Mary Quirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Quirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Quirk. The network helps show where Mary Quirk may publish in the future.

Co-authorship network of co-authors of Mary Quirk

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Quirk. A scholar is included among the top collaborators of Mary Quirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Quirk. Mary Quirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Sue, Ortwin Adams, Sunit‐Preet Chaudhry, et al.. (2024). Developing role of the myasthenia gravis nurse specialist. British Journal of Neuroscience Nursing. 20(5). 210–219.
2.
Quirk, Mary. (2006). Clostridium difficile epidemic strain far reaching. The Lancet Infectious Diseases. 6(2). 74–74. 2 indexed citations
3.
Quirk, Mary. (2005). Avian influenza vaccine clinical trial begins in USA. The Lancet Infectious Diseases. 5(5). 266–266. 1 indexed citations
4.
Quirk, Mary. (2004). USA establishes advisory board for “dual use” research. The Lancet Infectious Diseases. 4(5). 258–258. 1 indexed citations
5.
Quirk, Mary. (2004). Zoo tigers succumb to avian influenza. The Lancet Infectious Diseases. 4(12). 716–716. 9 indexed citations
6.
Quirk, Mary. (2004). USA to manufacture two million doses of pandemic flu vaccine. The Lancet Infectious Diseases. 4(11). 654–654. 1 indexed citations
7.
Quirk, Mary. (2003). HPV16 vaccine highly effective. The Lancet Infectious Diseases. 3(1). 5–5. 2 indexed citations
8.
Quirk, Mary. (2002). First treatment trial for West Nile infection begins. The Lancet Infectious Diseases. 2(10). 589–589. 6 indexed citations
9.
Quirk, Mary. (2002). CWD and neurological disease cluster link investigated. The Lancet Infectious Diseases. 2(11). 652–652. 1 indexed citations
10.
Quirk, Mary. (2001). Echovirus to be considered in meningitis diagnosis. The Lancet Infectious Diseases. 1(4). 220–220. 3 indexed citations
11.
Quirk, Mary. (2001). Antibiotic-resistant bacteria in food animals on the rise. The Lancet Infectious Diseases. 1(5). 293–293. 4 indexed citations
12.
Quirk, Mary, et al.. (1997). Propagation and titration of murine cytomegalovirus in a continuous bone marrow-derived stromal cell line (M2-10B4). Journal of Virological Methods. 68(2). 193–198. 22 indexed citations
13.
Boivin, Guy, Szu‐Yi Chou, Mary Quirk, Alejo Erice, & M C Jordan. (1996). Detection of Ganciclovir Resistance Mutations and Quantitation of Cytomegalovirus (CMV) DNA in Leukocytes of Patients with Fatal Disseminated CMV Disease. The Journal of Infectious Diseases. 173(3). 523–528. 62 indexed citations
14.
Boivin, Guy, et al.. (1996). Quantitation of Cytomegalovirus DNA and Characterization of Viral Gene Expression in Bronchoalveolar Cells of Infected Patients with and without Pneumonitis. The Journal of Infectious Diseases. 173(6). 1304–1312. 28 indexed citations
15.
Boivin, Guy, et al.. (1995). Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescence-based detection system. Journal of Virological Methods. 51(2-3). 329–342. 29 indexed citations
16.
Jordan, M. Colin, et al.. (1993). Recurrent Kaposi's sarcoma in a renal transplant recipient: Regression following treatment of cytomegaloviremia with ganciclovir. Clinical Transplantation. 7(5). 491–495. 3 indexed citations
17.
Saltzman, Robin, Mary Quirk, & M C Jordan. (1992). High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.. Journal of Clinical Investigation. 90(5). 1832–1838. 74 indexed citations
18.
Saltzman, Robin, Mary Quirk, Cary N. Mariash, & M. Colin Jordan. (1990). Quantitation of cytomegalovirus DNA by blot hybridization in blood leukocytes of viremic patients. Journal of Virological Methods. 30(1). 67–77. 18 indexed citations
19.
Saltzman, Robin, Mary Quirk, & M C Jordan. (1988). Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.. Journal of Clinical Investigation. 81(1). 75–81. 108 indexed citations
20.
Quirk, Mary, et al.. (1953). PERSONAL EQUATION AND THE MODERN MARINE SEXTANT. NAVIGATION Journal of the Institute of Navigation. 3(10). 353–356. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026